Safety and Efficacy of Brinzolamide Dosed TID With Dorzolamide Dosed TID in Reducing Intraocular Pressure in Patients With Open Angle Glaucoma or Ocular Hypertension
- First Posted Date
- 2008-09-30
- Last Posted Date
- 2012-07-18
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 200
- Registration Number
- NCT00761995
- Locations
- 🇮🇳
Alcon Laboratories, India, Bangalore, India
Phaco Versus Small Incision Cataract Surgery (SICS) Health Economic Study
Not Applicable
Completed
- Conditions
- Cataract
- Interventions
- Procedure: Phacoemulsification cataract extraction surgeryProcedure: Small incision cataract surgery
- First Posted Date
- 2008-09-30
- Last Posted Date
- 2012-10-31
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 106
- Registration Number
- NCT00762606
- Locations
- 🇺🇸
Alcon Call Center, Fort Worth, Texas, United States
Travatan Versus Timoptic in Treating Open-angle Glaucoma or Ocular Hypertension
Phase 4
Completed
- Conditions
- Glaucoma
- Interventions
- First Posted Date
- 2008-09-30
- Last Posted Date
- 2010-03-02
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 111
- Registration Number
- NCT00763061
- Locations
- 🇺🇸
Alcon Call Center, Fort Worth, Texas, United States
Posterior Capsule Opacification (PCO) Evaluation of the AcrySof SN60AT Lens vs. SN60WF Lens
Not Applicable
Completed
- Conditions
- Cataract
- Interventions
- Device: SN60ATDevice: SN60WF
- First Posted Date
- 2008-09-30
- Last Posted Date
- 2010-12-22
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 104
- Registration Number
- NCT00762021
- Locations
- 🇺🇸
Contact Alcon Call Center for Trial Locations, Fort Worth, Texas, United States
To Compare the Ability of DiscoVisc® OVD to Protect the Corneal Endothelium and Maintain Anterior Chamber Space With Healon® and Amvisc® PLUS During Cataract Surgery.
- First Posted Date
- 2008-09-30
- Last Posted Date
- 2012-01-24
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 184
- Registration Number
- NCT00763360
- Locations
- 🇺🇸
Alcon Call Center, Fort Worth, Texas, United States
Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG)
Phase 4
Completed
- Conditions
- Angle-closure Glaucoma
- Interventions
- First Posted Date
- 2008-09-30
- Last Posted Date
- 2023-12-06
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 30
- Registration Number
- NCT00762645
Rotational Stability of the AcrySof® Toric
Not Applicable
Completed
- Conditions
- Cataract
- Interventions
- Device: AcrySof® Toric intraocular lens
- First Posted Date
- 2008-09-30
- Last Posted Date
- 2012-10-31
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 71
- Registration Number
- NCT00762216
- Locations
- 🇺🇸
Alcon Call Center, Fort Worth, Texas, United States
Recommendations for Monitoring Clinical Experience Following Implantation of the AcrySof® Toric
Phase 4
Withdrawn
- Conditions
- Cataract
- Interventions
- Device: AcrySof® Toric IOL
- First Posted Date
- 2008-09-29
- Last Posted Date
- 2015-05-12
- Lead Sponsor
- Alcon Research
- Registration Number
- NCT00761488
- Locations
- 🇺🇸
Alcon Call Center, Fort Worth, Texas, United States
Phase III Clinical Trial of TRAVATAN Z in Ocular Surface Health
Phase 3
Completed
- Conditions
- Open-angle GlaucomaOcular Hypertension
- Interventions
- First Posted Date
- 2008-09-29
- Last Posted Date
- 2012-04-26
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 705
- Registration Number
- NCT00761319
Safety and Intraocular Pressure (IOP)-Lowering Efficacy of AL-39256 in Patients With Open-Angle Glaucoma or Ocular Hypertension
Phase 2
Completed
- Conditions
- Ocular HypertensionOpen-Angle Glaucoma
- Interventions
- First Posted Date
- 2008-09-29
- Last Posted Date
- 2014-07-15
- Lead Sponsor
- Alcon Research
- Target Recruit Count
- 104
- Registration Number
- NCT00761709
© Copyright 2025. All Rights Reserved by MedPath